Meeting Coverage

Serum creatinine shows potential as a non-cardiac biomarker for assessing mortality risk among patients with pulmonary embolism.

Research presented at the Fall Clinical Dermatology 2024 and published in the literature highlights the extensive impact of comorbidities in psoriasis.

Physician’s Weekly reviewed renal cell carcinoma-targeted research presented at the 2024 ESMO annual meeting.

Patients with autoimmune diseases, including psoriasis, are at higher risk for being diagnosed with latent autoimmune diabetes in adults, or LADA.

In COPD, rural women continue to experience a higher burden than urban women regarding other health conditions, access to care, and poverty.

In a commentary for the Journal of Investigative Dermatology, Joel M. Gelfand, MD, discusses psoriasis treatment, recent advances, and the potential for a cure.

NSAIDs, particularly when combined with acetaminophen, are the preferred choice for managing pain following tooth extractions.

During the 2024 AAO annual meeting, researchers presented various studies on retinal disease and treatment options.

During the 2024 AAO Annual Meeting, presenters discussed various posters and research on retinal vascular health.

During the 2024 annual ESMO Congress, multiple poster sessions focused on the treatment of renal cell carcinoma (RCC).

Even after treatment with inhaled corticosteroids alone or in combination with long-acting antagonists, lung function decline continues in uncontrolled asthma.

During the 106th AAOMS Annual Meeting, Scientific Session and Exhibition, various sessions covered acute dental pain while lowering opioid use among these patients.

The TMD Pain Screener was useful for ruling out whether tooth pain presenting in patients to endodontists had temporomandibular joint disorders.

Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.